Your browser doesn't support javascript.
loading
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study.
Barbui, Tiziano; Ghirardi, Arianna; Masciulli, Arianna; Carobbio, Alessandra; Palandri, Francesca; Vianelli, Nicola; De Stefano, Valerio; Betti, Silvia; Di Veroli, Ambra; Iurlo, Alessandra; Cattaneo, Daniele; Delaini, Federica; Bonifacio, Massimiliano; Scaffidi, Luigi; Patriarca, Andrea; Rumi, Elisa; Casetti, Ilaria Carola; Stephenson, Clemency; Guglielmelli, Paola; Elli, Elena Maria; Palova, Miroslava; Bertolotti, Laura; Erez, Daniel; Gomez, Montse; Wille, Kai; Perez-Encinas, Manuel; Lunghi, Francesca; Angona, Anna; Fox, Maria Laura; Beggiato, Eloise; Benevolo, Giulia; Carli, Giuseppe; Cacciola, Rossella; McMullin, Mary Frances; Tieghi, Alessia; Recasens, Valle; Marchetti, Monia; Griesshammer, Martin; Alvarez-Larran, Alberto; Vannucchi, Alessandro Maria; Finazzi, Guido.
Afiliação
  • Barbui T; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy. tbarbui@fondazionefrom.it.
  • Ghirardi A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Masciulli A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Carobbio A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Palandri F; Institute of Hematology "L. and A. Seràgnoli", S. Orsola-Malpighi Hospital, Bologna, Italy.
  • Vianelli N; Institute of Hematology "L. and A. Seràgnoli", S. Orsola-Malpighi Hospital, Bologna, Italy.
  • De Stefano V; Institute of Hematology, Catholic University, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
  • Betti S; Institute of Hematology, Catholic University, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
  • Di Veroli A; Rete laziale MPN, Roma, Italy.
  • Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy.
  • Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy.
  • Delaini F; Hematology Division, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Bonifacio M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Scaffidi L; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Patriarca A; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Rumi E; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Casetti IC; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo Pavia, Pavia, Italy.
  • Stephenson C; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Guglielmelli P; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Elli EM; CRIMM-Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, Department of Experimental and Clinical Medicine, and Denothe Center, University of Florence, Florence, Italy.
  • Palova M; Hematology Division, Ospedale San Gerardo, ASST Monza, Monza, Italy.
  • Bertolotti L; Department of Hemato-oncology, University Hospital Olomouc, Olomouc, Czech Republic.
  • Erez D; S.C. Ematologia, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy.
  • Gomez M; Hematology Institute and Blood Bank, Meir Medical Center, Kfar Saba, Israel.
  • Wille K; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Perez-Encinas M; Hematology Department, Hospital Clínico Universitario, Valencia, Spain.
  • Lunghi F; University Clinic for Hematology and Oncology Minden, University of Bochum, Bochum, Germany.
  • Angona A; Hematology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Fox ML; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Beggiato E; Hematology Department, Hospital del Mar, Barcelona, Spain.
  • Benevolo G; Hematology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Carli G; Unit of Hematology, Department of Oncology, University of Torino, Torino, Italy.
  • Cacciola R; Hematology Division, Città della Salute e della Scienza Hospital, Torino, Italy.
  • McMullin MF; Hematology Division, San Bortolo Hospital, Vicenza, Italy.
  • Tieghi A; HAEMOSTASIS UNIT, Department of Clinical and Experimental Medicine, University of Catania, "Policlinico-Vittorio Emanuele" Hospital, Catania, Italy.
  • Recasens V; Queen's University, Belfast, UK.
  • Marchetti M; Hematology Unit, Azienda Unità Sanitaria-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Griesshammer M; Hematology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Alvarez-Larran A; Oncology Unit, Cardinal Massaia Hospital, Asti, Italy.
  • Vannucchi AM; University Clinic for Hematology and Oncology Minden, University of Bochum, Bochum, Germany.
  • Finazzi G; Hematology Department, Hospital Clínic, Barcelona, Spain.
Leukemia ; 33(8): 1996-2005, 2019 08.
Article em En | MEDLINE | ID: mdl-31142846
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Policitemia Vera / Cromossomo Filadélfia / Segunda Neoplasia Primária / Mielofibrose Primária / Trombocitemia Essencial / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Policitemia Vera / Cromossomo Filadélfia / Segunda Neoplasia Primária / Mielofibrose Primária / Trombocitemia Essencial / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article